Dear colleagues,
Cardiovascular diseases represent the predominant global cause of mortality, contributing to an alarming 32% of all deaths in 2019. The confluence of metabolic diseases, particularly diabetes, further accentuates the risk and severity of cardiovascular issues within this landscape. With an estimated 422 million individuals worldwide with diabetes, and 1.5 million deaths annually directly attributed to this condition, a critical imperative emerges—to comprehensively address cardiovascular outcomes in this specific patient cohort.
In the past decade, there has been a notable escalation in the incidence of chronic liver disease, primarily associated with non-alcoholic/metabolic dysfunction-associated fatty liver disease, impacting 25% of the global population. Against this backdrop, cardiovascular disease has emerged as a leading cause of mortality. Recognizing the intricate interplay of these health concerns and their profound implications for clinical practice and public health, Reviews in Cardiovascular Medicine is unveiling a Special Issue titled "Cardiovascular Outcomes and Disease Management in Diabetic and Liver Patients." The objective is to compile precise and up-to-date scientific information across all facets of innovative treatments and disease management strategies, with the ultimate aim of enhancing cardiovascular outcomes in individuals navigating the complex intersection of diabetes and liver disorders.
It is both an honor and a privilege to extend an invitation to you and your esteemed colleagues to contribute to this collective effort. We welcome original research articles, systematic reviews, and review articles that illuminate new perspectives, ideas, and recent advances in the dynamic field of cardiovascular outcomes and disease management in diabetic and liver patients. Your valuable contributions will undoubtedly enrich the scientific literature and pave the way for improved healthcare practices in these challenging clinical settings.
Dr. Alfredo Caturano
Guest Editor
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.